【レポートの概要（一部）】
Table of Contents
Chapter 1 Research Methodology
1.1 Country-Wise Market: Base Estimates
1.2 Global Market: CAGR Calculation
1.3 Region-Based Segment Share Calculation
1.4 Research Scope & Assumptions
1.5 List of Data Sources
1.5.1 Data for primary interviews, by sources
1.5.2 Data for primary interviews, by region
Chapter 2 Executive Summary
2.1 Market Snapshot
Chapter 3 Glycomics/Glycobiology Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.2 Market Driver Analysis
3.2.1 Increasing focus on glycomics and proteomics research
3.2.2 Increasing investment in R&D by research institutes and pharmaceutical & biotechnology companies
3.2.3 Technological advancements in glycomics instruments
3.2.4 Untapped opportunities in developing region
3.3 Market Restraint Analysis
3.3.1 Stringent government policies and regulations
3.4 Key Opportunities Prioritized
3.4.1 Key opportunities prioritized, by product
3.4.2 Key opportunities prioritized, by application
3.4.3 Key opportunities prioritized, by end use
3.5 Glycomics/Glycobiology – SWOT Analysis, By Factor (political & legal, economic and technological)
3.6 Industry Analysis – Porter’s
3.7 Glycomics/Glycobiology Market: Market Position Analysis
Chapter 4 Glycomics/Glycobiology: Product Estimates & Trend Analysis
4.1 Glycomics/Glycobiology market: Product movement analysis
4.2 Instruments
4.2.1 Instruments market, 2014 – 2025 (USD Million)
4.2.2 Mass spectrometers
4.2.2.1 Mass spectrometers market, 2014 – 2025 (USD Million)
4.2.3 HPLC
4.2.3.1 HPLC market, 2014 – 2025 (USD Million)
4.2.4 MALDI-TOF mass spectrometers
4.2.4.1 MALDI-TOF mass spectrometers market, 2014 – 2025 (USD Million)
4.2.5 Array systems
4.2.5.1 Array systems market, 2014 – 2025 (USD Million)
4.2.6 Other instruments
4.2.6.1 Other instruments market, 2014 – 2025 (USD Million)
4.3 Reagents
4.3.1 Reagents market, 2014 – 2025 (USD Million)
4.3.2 Glycoproteins
4.3.2.1 Glycoproteins market, 2014 – 2025 (USD Million)
4.3.3 Monosaccharides
4.3.3.1 Monosaccharides market, 2014 – 2025 (USD Million)
4.3.4 Oligosaccharides
4.3.4.1 Oligosaccharides market, 2014 – 2025 (USD Million)
4.3.5 Other reagents
4.3.5.1 Other reagents market, 2014 – 2025 (USD Million)
4.4 Kits
4.4.1 Kits market, 2014 – 2025 (USD Million)
4.4.2 Glycan labeling kits
4.4.2.1 Glycan labeling kits market, 2014 – 2025 (USD Million)
4.4.3 Glycan purification kits
4.4.3.1 Glycan purification kits market, 2014 – 2025 (USD Million)
4.4.4 Glycan release kits
4.4.4.1 Glycan release kits market, 2014 – 2025 (USD Million)
4.4.5 Other kits
4.4.5.1 Other kits market, 2014 – 2025 (USD Million)
4.5 Enzymes
4.5.1 Enzymes market, 2014 – 2025 (USD Million)
4.5.2 Glycosidases
4.5.2.1 Glycosidases market, 2014 – 2025 (USD Million)
4.5.3 Glycosyltransferases
4.5.3.1 Glycosyltransferases market, 2014 – 2025 (USD Million)
4.5.4 Neuraminidases
4.5.4.1 Neuraminidases market, 2014 – 2025 (USD Million)
4.5.5 Sialyltransferases
4.5.5.1 Sialyltransferases market, 2014 – 2025 (USD Million)
4.5.6 Other enzymes
4.5.6.1 Other enzymes market, 2014 – 2025 (USD Million)
Chapter 5 Glycomics/Glycobiology: Application Estimates & Trend Analysis
5.1 Glycomics/Glycobiology Market: Application Movement Analysis
5.2 Drug Discovery & Development
5.2.1 Drug discovery & development Market, 2014 – 2025 (USD Million)
5.3 Diagnostics
5.3.1 Diagnostics Market, 2014 – 2025 (USD Million)
5.4 Other Application
5.4.1 Other application Market, 2014 – 2025 (USD Million)
Chapter 6 Glycomics/Glycobiology: End-use Estimates & Trend Analysis
6.1 Glycomics/Glycobiology Market: End-Use Movement Analysis
6.2 Academic & Research Institutes
6.2.1 Academic & research institutes market, 2014 – 2025 (USD Million)
6.3 Pharmaceutical & Biotechnology Companies
6.3.1 Pharmaceutical & biotechnology companies market, 2014 – 2025 (USD Million)
6.4 CROs
6.4.1 CROs market, 2014 – 2025 (USD Million)
Chapter 7 Glycomics/Glycobiology: Regional Estimates & Trend Analysis, by Product, Application, End-use
7.1 Glycomics/Glycobiology Market Share By Region, 2016 & 2025
7.2 North America
7.2.1 North America glycomics/glycobiology market, by product, 2014 – 2025 (USD Million)
7.2.2 North America glycomics/glycobiology market, by application, 2014 – 2025 (USD Million)
7.2.3 North America glycomics/glycobiology market, by end use, 2014 – 2025 (USD Million)
7.2.4 U.S.
7.2.4.1 U.S. glycomics/glycobiology market, by product, 2014 – 2025 (USD Million)
7.2.4.2 U.S. glycomics/glycobiology market, by application, 2014 – 2025 (USD Million)
7.2.4.3 U.S. glycomics/glycobiology market, by end use, 2014 – 2025 (USD Million)
7.2.5 Canada
7.2.5.1 Canada glycomics/glycobiology market, by product, 2014 – 2025 (USD Million)
7.2.5.2 Canada glycomics/glycobiology market, by application, 2014 – 2025 (USD Million)
7.2.5.3 Canada glycomics/glycobiology market, by end use, 2014 – 2025 (USD Million)
7.3 Europe
7.3.1 Europe glycomics/glycobiology market, by product, 2014 – 2025 (USD Million)
7.3.2 Europe glycomics/glycobiology market, by application, 2014 – 2025 (USD Million)
7.3.3 Europe glycomics/glycobiology market, by end use, 2014 – 2025 (USD Million)
7.3.4 Germany
7.3.4.1 Germany glycomics/glycobiology market, by product, 2014 – 2025 (USD Million)
7.3.4.2 Germany glycomics/glycobiology market, by application, 2014 – 2025 (USD Million)
7.3.4.3 Germany glycomics/glycobiology market, by end use, 2014 – 2025 (USD Million)
7.3.5 UK
7.3.5.1 UK glycomics/glycobiology market, by product, 2014 – 2025 (USD Million)
7.3.5.2 UK glycomics/glycobiology market, by application, 2014 – 2025 (USD Million)
7.3.5.3 UK glycomics/glycobiology market, by end use, 2014 – 2025 (USD Million)
7.4 Asia Pacific
7.4.1 Asia Pacific glycomics/glycobiology market, by product, 2014 – 2025 (USD Million)
7.4.2 Asia Pacific glycomics/glycobiology market, by application, 2014 – 2025 (USD Million)
7.4.3 Asia Pacific glycomics/glycobiology market, by end use, 2014 – 2025 (USD Million)
7.4.4 Japan
7.4.4.1 Japan glycomics/glycobiology market, by product, 2014 – 2025 (USD Million)
7.4.4.2 Japan glycomics/glycobiology market, by application, 2014 – 2025 (USD Million)
7.4.4.3 Japan glycomics/glycobiology market, by end use, 2014 – 2025 (USD Million)
7.4.5 China
7.4.5.1 China glycomics/glycobiology market, by product, 2014 – 2025 (USD Million)
7.4.5.2 China glycomics/glycobiology market, by application, 2014 – 2025 (USD Million)
7.4.5.3 China glycomics/glycobiology market, by end use, 2014 – 2025 (USD Million)
7.4.6 India
7.4.6.1 India glycomics/glycobiology market, by product, 2014 – 2025 (USD Million)
7.4.6.2 India glycomics/glycobiology market, by application, 2014 – 2025 (USD Million)
7.4.6.3 India glycomics/glycobiology market, by end use, 2014 – 2025 (USD Million)
7.5 Latin America
7.5.1.1 Latin America glycomics/glycobiology market, by product, 2014 – 2025 (USD Million)
7.5.1.2 Latin America glycomics/glycobiology market, by application, 2014 – 2025 (USD Million)
7.5.1.3 Latin America glycomics/glycobiology market, by end use, 2014 – 2025 (USD Million)
7.5.2 Brazil
7.5.2.1 Brazil glycomics/glycobiology market, by product, 2014 – 2025 (USD Million)
7.5.2.2 Brazil glycomics/glycobiology market, by application, 2014 – 2025 (USD Million)
7.5.2.3 Brazil glycomics/glycobiology market, by end use, 2014 – 2025 (USD Million)
7.5.3 Mexico
7.5.3.1 Mexico glycomics/glycobiology market, by product, 2014 – 2025 (USD Million)
7.5.3.2 Mexico glycomics/glycobiology market, by application, 2014 – 2025 (USD Million)
7.5.3.3 Mexico glycomics/glycobiology market, by end use, 2014 – 2025 (USD Million)
7.6 MEA
7.6.1 MEA glycomics/glycobiology market, by product, 2014 – 2025 (USD Million)
7.6.2 MEA glycomics/glycobiology market, by application, 2014 – 2025 (USD Million)
7.6.3 MEA glycomics/glycobiology market, by end use, 2014 – 2025 (USD Million)
7.6.4 South Africa
7.6.4.1 South Africa glycomics/glycobiology market, by product, 2014 – 2025 (USD Million)
7.6.4.2 South Africa glycomics/glycobiology market, by application, 2014 – 2025 (USD Million)
7.6.4.3 South Africa glycomics/glycobiology market, by end use, 2014 – 2025 (USD Million)
Chapter 8 Competitive Landscape
8.1 Strategy Framework
8.2 Company Profiles
8.2.1 Danaher
8.2.1.1 Company overview
8.2.1.2 Financial performance
8.2.1.3 Product benchmarking
8.2.1.4 Strategic initiatives
8.2.2 Agilent Technologies
8.2.2.1 Company overview
8.2.2.2 Financial performance
8.2.2.3 Product benchmarking
8.2.2.4 Strategic initiatives
8.2.3 Thermo Fisher Scientific, Inc.
8.2.3.1 Company overview
8.2.3.2 Financial performance
8.2.3.3 Product benchmarking
8.2.3.4 Strategic initiatives
8.2.4 ProZyme
8.2.4.1 Company overview
8.2.4.2 Financial performance
8.2.4.3 Product benchmarking
8.2.4.4 Strategic initiatives
8.2.5 Shimadzu Corporation
8.2.5.1 Company overview
8.2.5.2 Financial performance
8.2.5.3 Product benchmarking
8.2.5.4 Strategic initiatives
8.2.6 Bruker
8.2.6.1 Company overview
8.2.6.2 Financial performance
8.2.6.3 Product benchmarking
8.2.6.4 Strategic initiatives
8.2.7 Merck KGaA
8.2.7.1 Company overview
8.2.7.2 Financial performance
8.2.7.3 Product benchmarking
8.2.7.4 Strategic initiatives
8.2.8 Takara Bio, Inc.
8.2.8.1 Company overview
8.2.8.2 Financial performance
8.2.8.3 Product benchmarking
8.2.8.4 Strategic initiatives
8.2.9 New England Biolabs
8.2.9.1 Company overview
8.2.9.2 Financial performance
8.2.9.3 Product benchmarking
8.2.9.4 Strategic initiatives
8.2.10 Waters Corporation
8.2.10.1 Company overview
8.2.10.2 Financial performance
8.2.10.3 Product benchmarking
8.2.10.4 Strategic initiatives
【レポート販売概要】
■ タイトル：グライコミクス/糖鎖生物学の世界市場分析：製品別（酵素、キット、試薬、機器）、用途別（創薬および開発、診断）、エンドユーザー別、セグメント予測、2014-2025■ 英文：Glycomics/Glycobiology Market Analysis By Product (Enzymes, Kits, Reagents, Instruments), By Application (Drug Discovery & Development, Diagnostics), By End-use, And Segment Forecasts, 2014-2025
■ 発行日：2017年4月26日
■ 調査会社：Grand View Research
■ 商品コード：GVIEW707371
■ 調査対象地域：グローバル
- 世界のOTC医薬品（大衆薬）市場動向（2012-2016）TechNavio's analysts forecast the Global Over-the-counter (OTC) Pharmaceutical market to grow at a CAGR of 1.9 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing switch from prescription to OTC drugs. The Global Over-the-counter Pharmaceutical market has also been witnessing the trend of an increasing number of mergers and acquisitions. H …
- 世界の調理済み動物飼料市場（～2019）The expansion of the global prepared animal feed industry is forecast to reach 4.0% p.a. in the coming years. Between 2008 and 2014 the market increased with an average annual growth of 9.5%. Currently, cat and dog food accounts for 41.0% of the global demand while the remaining market share is divided between lucerne (alfalfa) pellets and meal (1.1%) and other prepared animal feeds (57.9%). China …
- 世界の注入型ドラッグデリバリー（薬物送達）市場The global injectable drug delivery technologies market was valued at $22.5 billion in 2012, and is expected to reach $43.3 billion by 2017 at a CAGR of 14.0% from 2012 to 2017. Injectable drug delivery technologies are the combination of two major segments; devices and formulations. The global injectable drug delivery formulations technologies market was the largest segment in this market. This i …
- チューブ包装パッケージの世界市場：積層チューブ、アルミニウムチューブ、プラスチックチューブThe tube packaging market includes all the types of tubes such as squeeze tubes, twist tubes, and other tubes. The tube packaging market has varied applications, such as cosmetics & oral care, food & beverages, pharmaceuticals, consumer goods, and others. Tubes possess properties such as excellent barrier properties, convenient packaging, which fuel the growth of the tube packaging market. The mar …
- Black Hills Corporation：石油・ガスバリューチェーン分析レポート2013Black Hills Corporation Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Black Hills Corporation" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Black Hills Corporation”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The re …
- Liver Fibrosis：グローバル臨床試験レビューH1, 2013Liver Fibrosis Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Liver Fibrosis Global Clinical Trials Review, H1, 2013" provides data on the Liver Fibrosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Liver Fibrosis. It includes an overview of the trial numbers and their recruitment status as per …
- 世界の船舶用コーティング市場動向（2014-2018）TechNavio's analysts forecast the Global Marine Coatings market to grow at a CAGR of 11.29 percent over the period 2013-2018. One of the key factors contributing to this market growth is the expansion of the Oil and Gas market. The Global Marine Coatings market has also been witnessing the growing consumer preference for eco-friendly products; however, the strict environmental regulations could po …
- アルミニウムダイカスト機械の世界市場：HPDC、LPDC、その他Global Aluminum Die Casting Machinery Market: About this market Technavio’s aluminum die casting machinery market analysis considers sales from HPDC, LPDC, and others. Our analysis also considers the sales of aluminum die casting machinery in APAC, Europe, MEA, North America, and South America. In 2018, the HPDC segment had a significant market share, and this trend is expected to continue over th …
- 食品用安定剤の世界市場About Food Stabilizers Food stabilizers are added to stabilize and improve the texture, prevent crystallization (sugar and ice), stabilize foams and emulsions, reduce the stickiness of icings on baked products, and to retain moisture and flavor of food products. Polysaccharide gum, arabic gum, and guar gum are the most commonly used stabilizers and thickeners. Gelatin is another commonly used non- …
- 世界の予測分析市場（企業IT）：Global Predictive Analytics Market 2014-2018TechNavio's analysts forecast the Global Predictive Analytics market to grow at a CAGR of 30.19 percent over the period 2014-2018. One of the key factors contributing to this market growth is the increasing need of enterprises to remain competitive in the market. The Global Predictive Analytics market has also been witnessing the emergence of cloud-based predictive analytics. However, the lack of …
- EOG Resources, Inc.：石油・ガスの開発・生産動向及びコスト分析- Q2, 2013EOG Resources, Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - Q2, 2013 Summary EOG Resources, Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for …
- 完成車ロジスティクスの世界市場2019-2023Global Finished Vehicles Logistics Market: About this market Technavio’s finished vehicles logistics market analysis considers sales from road, rail, sea, and air. Our analysis also considers the sales of finished vehicles logistics in APAC, Europe, North America, South America, and MEA. In 2018, the road segment had a significant market share, and this trend is expected to continue over the forec …
- 世界のメシチレン市場2015The Global Mesitylene Industry Report 2015 is a professional and in-depth study on the current state of the Mesitylene industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Mesitylene market analysis is provided for the international markets including development trends, competitive landscape analysis, …
- 世界の髄膜炎菌ワクチン市場（2014-2018）About Meningococcal Vaccines Meningitis is characterized by the inflammation of the protective lining (meninges) present around the brain and the spinal cord. On the basis of its underlying cause, meningitis can be classified into infectious and non-infectious meningitis. In terms of the type of organism, infectious meningitis can be sub-divided into bacterial meningitis, viral meningitis, fungal …
- 巨細胞動脈炎：治療薬のグローバル治験動向（2014年下半期）Giant Cell Arteritis Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Giant Cell Arteritis Global Clinical Trials Review, H2, 2014" provides data on the Giant Cell Arteritis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Giant Cell Arteritis. It includes an overview of the trial numbers and their r …
